GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (XAMS:KDS) » Definitions » Institutional Ownership

Kiadis Pharma NV (XAMS:KDS) Institutional Ownership : 6.24% (As of May. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kiadis Pharma NV's institutional ownership is 6.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kiadis Pharma NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kiadis Pharma NV's Float Percentage Of Total Shares Outstanding is 0.00%.

Kiadis Pharma NV Institutional Ownership Historical Data

The historical data trend for Kiadis Pharma NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Institutional Ownership Chart

Kiadis Pharma NV Historical Data

The historical data trend for Kiadis Pharma NV can be seen below:

2020-07-31 2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31 2021-01-31 2021-02-28 2021-03-31 2021-04-30
Institutional Ownership 3.90 3.86 3.82 3.65 5.27 5.75 5.66 6.01 6.24 6.24

Kiadis Pharma NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Kiadis Pharma NV (XAMS:KDS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (XAMS:KDS) » Definitions » Institutional Ownership
Comparable Companies
XAMS:VVY OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY HKSE:02269 OCSE:GMAB HKSE:01177 BMRN SZSE:300122 XBRU:UCB ALNY XAMS:GLPG HKSE:06160
Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Website
https://www.kiadis.com
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (XAMS:KDS) Headlines

No Headlines